Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, &

Status Completed

Clinical Trial Summary

Oxidative stress, which refers to cellular damage caused by reactive oxygen intermediates, has been implicated in many disease processes, especially age-related disorders. Many trials investigating use of antioxidants in protecting different tissues against oxidative stress have been conducted, but the results are ambiguous.

Inflammation is generally associated with enhanced oxidative stress and widespread endothelial dysfunction. In the present study, the infusion of LPS, which is a cell wall component of Gram-negative bacteria and a major mediator in the pathogenesis of septic shock, will be used as a standardized experimental model of systemic inflammatory response in humans. The assessment of outcome parameters will include measurements of ocular blood flow, forearm blood flow and plasma concentration of cytokines. Measurements of ocular hemodynamics provide an unique chance to investigate local blood flow in humans non-invasively. Moreover, the retina is especially susceptible to oxidative stress because of its high consumption of oxygen, its high polyunsaturated fatty acid content, and its exposure to visible light. Evidence from literature clearly supports a role for oxidative stress in pathophysiology of several ocular diseases including diabetic retinopathy and age-related macular degeneration. To investigate the retinal vascular reactivity we will use systemic hyperoxia as a stimulus. The measurement of forearm blood flow will be use to assess endothelial function. The main study objective is to investigate the effect of oral vitamins and minerals supplementation on impaired retinal vascular reactivity after LPS administration.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00431691
Study type	Interventional
Source	Medical University of Vienna
Contact
Status	Completed
Phase	Phase 4
Start date	September 2006
Completion date	December 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01734616` - Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance in Older People	N/A
Completed	`NCT00810927` - Role of Nitrogen Oxide (NO) in the Control of Choroidal Blood Flow During a Decrease in Ocular Perfusion Pressure	Phase 2
Completed	`NCT00431392` - Mechanisms of Choroidal Blood Flow Changes During Dark/Light Transitions	Phase 2
Completed	`NCT00540215` - GLP-2 (Glucagonlike Peptide-2) and Blood Flow	N/A
Completed	`NCT02589054` - Regional Changes in Upper Limb Perfusion Following Brachial Plexus Block: A Pilot Study	N/A
Completed	`NCT00707226` - Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes	N/A
Completed	`NCT00709449` - An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects	Phase 2/Phase 3
Terminated	`NCT00708357` - Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?	Phase 0
Terminated	`NCT00709657` - The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion	N/A
Completed	`NCT00709423` - Effects of Moxaverine and Placebo on Ocular Blood Flow	Phase 2
Completed	`NCT00814008` - The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp	Phase 2
Completed	`NCT00708929` - Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid?	N/A
Completed	`NCT00712400` - Effects of Latanoprost on Choroidal Blood Flow Regulation in Human Subjects	N/A
Completed	`NCT00312325` - Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans	Phase 4
Withdrawn	`NCT00312390` - Amblyopia and Neurovascular Coupling in the Retina of Humans	N/A
Withdrawn	`NCT00406731` - Role of Endothelin- and Nitric Oxide-system in the Regulation of Optic Nerve Head Blood Flow During Changes in Ocular Perfusion Pressure	Phase 2
Completed	`NCT00275730` - Effects of Indomethacin on Retinal and Choroidal Blood Flow in Healthy Volunteers	N/A
Completed	`NCT00312416` - Effects of Topical Clonidine vs. Brimonidine on Choroidal Blood Flow and Intraocular Pressure During Isometric Exercise	Phase 4
Completed	`NCT00712907` - Effects of Vitamin C on Hyperoxia-Induced Reduction of Retinal Blood Flow	N/A
Withdrawn	`NCT02978560` - Indocyanine Green Tissue Perfusion Monitoring

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, and Cytokine Levels in LPS Induced Inflammatory Model in Humans.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms